Abiomed Forecasts Recover Micropump U.S. Approval In 2006
Abiomed expects profitability in 2007 following U.S. approval of Recover 5.0 and 2.5 second-generation micropumps, which it acquired from Impella CardioSystems AG in April
Abiomed expects profitability in 2007 following U.S. approval of Recover 5.0 and 2.5 second-generation micropumps, which it acquired from Impella CardioSystems AG in April